GenMark Diagnostics Announces Positive Preliminary Q1 Financial Results And ePlex Update
CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced positive preliminary first quarter 2015 results, and an update on the commercial launch of its ePlex sample-to-answer system.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.